Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Solid Therapeutics ApS
APS
Active
CVR 43007068
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
3 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Solid Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2022
-3M
2023
-4M
2024
EBITDA
DKK millions
0M
-2M
-4M
-7M
-9M
-1M
2022
-4M
-300%
2023
-7M
-75%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
-398
-2.739
-4.214
Staff expenses
-364
-1.454
-3.033
EBITDA
-762
-4.193
-7.247
Depreciation & amort.
-0
-0
-0
EBIT
-762
-4.193
-7.247
Net financials
-113
-167
-1.065
Profit before tax
-875
-4.360
-8.312
Tax
-78
-877
-1.554
Net profit
-797
-3.483
-6.758
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
3.575
10.813
11.004
Equity
-757
-4.240
-10.998
Long-term debt
4.093
14.256
20.308
Short-term debt
239
797
1.694
Total debt
4.332
15.053
22.002
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-724705900.0%
This company
2022
2024
Soliditetsgrad
-99.9%
This company
38.2%
Market median
-362% vs market
2022
2024
Egenkapitalforrentning
-675820700.0%
This company
18.4%
Market median
-3672938687% vs market
2022
2024
Nettoresultatgrad (af bruttofortjeneste)
-675820700.0%
This company
2022
2024
Aktivomsætning (af bruttofortjeneste)
-0.38×
This company
2022
2024
Gæld/egenkapital
2.00×
This company
0.62×
Market median
-223% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-21 – 2022-12-31
View
PDF
More on Solid Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
